Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection (Q35598552)
Jump to navigation
Jump to search
scientific article published on 26 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection |
scientific article published on 26 September 2011 |
Statements
1 reference
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection (English)
1 reference
Paul Covington
1 reference
J Michael Davenport
1 reference
David Andrae
1 reference
William O'Riordan
1 reference
Lisa Liverman
1 reference
Gail McIntyre
1 reference
June Almenoff
1 reference
26 September 2011
1 reference
1 reference
Identifiers
1 reference